EIS

Equity ETFs

Teva/Mylan Deal Doesn’t Stir Pharma ETFs

By Todd ShriberApril 17, 2015

Equity ETFs

Pharma Focus Fabulous for Israel ETFs

By Todd ShriberApril 15, 2015

Equity ETFs

Healthcare Exposure Lifts Some International ETFs

By Todd ShriberApril 2, 2015

Equity ETFs

Central Bank Rate Cut, Loose Policies to Bolster Israel ETFs

By Tom LydonFebruary 24, 2015

Featured

Tel Aviv Shake-Up Could Bring Israel to MSCI Europe ETFs

By Tom LydonAugust 27, 2014

Featured

Geopolitical Uncertainty Weighs on Israel ETFs

By Max ChenJuly 8, 2014

Equity ETFs

Israel Intrigue With ETFs

By Tom LydonApril 23, 2014

Equity ETFs

Momentum With Israel ETFs

By Todd ShriberMarch 19, 2014

Equity ETFs

Illuminating Israel ETFs

By Max ChenMarch 11, 2014

Equity ETFs

Teva Takeover Would Send This ETF Soaring

By Tom LydonFebruary 24, 2014

Equity ETFs

A Surprising Region Leads Foreign ETFs in 2014

By Todd ShriberJanuary 30, 2014

Equity ETFs

Israel ETFs Breakout

By Tom LydonJanuary 17, 2014

Equity ETFs

Israel’s Booming Startup Scene Could Lift This ETF

By Tom LydonDecember 31, 2013

Equity ETFs

Inexpensive Global Markets Delivered This Year

By Todd ShriberDecember 6, 2013

Equity ETFs

ETF Spotlight: Market Vectors Israel

By Tom LydonOctober 28, 2013

Featured

ETF Opportunities as Budget Deal Affects U.S. Growth

By Tom LydonJanuary 18, 2013

Featured

Tom Lydon, Chuck Jaffe Talk ETF of the Week: Israel

By Tom LydonOctober 25, 2012

Equity ETFs

The Contrarian: Single-Country ETFs

By Tom LydonAugust 23, 2011